ARCHIVES

In Brief: NCI Recieves Two Proposals For Antineoplaston Trials, None For Children; Stubble Elected To NAS

This article is from The Cancer Letter archive.

Vol. 18 No. 25 | June 19, 1992

Download PDF Visit The Full Archive

Related Articles

Satraplatin Improved PFS In Refractory Prostate Cancer

July 25, 2003

NIH Faces Cuts Under House, Senate, Administration Plans

May 19, 1995

Brachytherapy Prevents Endometrial Cancer Return

June 27, 2008

Regulatory Approvals: FDA expanded the approved use of Cyramza to include metastatic NSCLC

December 19, 2014

Wistar Investigators Report Oncogene Relation to Burkitt’s

November 26, 1982

SEC Notifies ImClone It May Bring Action Against Company

June 21, 2002